PRESS RELEASE published on 07/24/2024 at 17:57, 3 months 27 days ago Ipsos: Total growth of 4.7% and good profitability and cash generation in the first half Ipsos reports total growth of 4.7%, with strong profitability and cash generation in the first half of the year. Organic growth at 3.8%. Financial performance shows operating margin at 10.1% and free cash flow of €80 million Financial Performance Profitability Cash Generation Ipsos Total Growth
BRIEF published on 06/11/2024 at 19:28, 5 months 9 days ago Success of the "Ipsos Partnership 2024" Operation Shareholders Investment 2024 Ipsos DT & Partners
PRESS RELEASE published on 06/11/2024 at 19:23, 5 months 9 days ago Success of the "Ipsos Partnership 2024" operation Ipsos Partners' success with 'Ipsos Partnership 2024' operation involving global executives investing in DT & Partners, enhancing Ipsos' position and stability. Didier Truchot and Ben Page acknowledge the operation's achievement Investment Executives DT & Partners Ipsos Partners Ipsos Partnership 2024
BRIEF published on 05/27/2024 at 19:43, 5 months 24 days ago Ipsos: Monthly Declaration of Shares and Voting Rights - April 2024 Voting Rights Shares AMF Regulations April 2024 Ipsos
PRESS RELEASE published on 05/27/2024 at 19:38, 5 months 24 days ago Ipsos: Monthly declaration of shares and voting rights - April 2024 Ipsos monthly disclosure of total shares and voting rights. As of April 30, 2024, they have 43,203,225 shares with 48,662,330 theoretical voting rights and 48,289,156 exercisable voting rights Voting Rights AMF Monthly Disclosure Total Shares Ipsos
BRIEF published on 05/07/2024 at 17:57, 6 months 13 days ago Ipsos announces its share buybacks for the period from April 29 to May 3, 2024 Share Buyback Financial Markets Ipsos FR0000073298 April-May 2024
PRESS RELEASE published on 05/07/2024 at 17:52, 6 months 13 days ago Ipsos: Disclosure of trading in own shares under a share buyback programme (29 april to 3 May 2024) Ipsos discloses trading in own shares under share buyback program from 29 April to 3 May 2024. Detailed transactions available on company's website Transactions Shares Trading Buyback Program Ipsos
Published on 11/21/2024 at 13:30, 20 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 20 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 50 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 50 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 50 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 14 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 34 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 29 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
